Musaffa Logo
Trifecta Gold Ltd TRRFF
$0.14 $0.00 (1.35%) 1D

Last Updated: Aug 21, 12:00 AM·OOTC

Pricing for US stocks is delayed by 24 hours

TRRFF Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Trifecta Gold Ltd is classified as not halal.

NOT HALAL

Report Source: undefined Quarter Report

Trifecta Gold Ltd

Trifecta Gold Ltd. Stock Analysis TRRFF

United States N/A Nano Cap

Trifecta Gold Ltd (TRRFF) Chart

Financial Metrics & Statements of Trifecta Gold Ltd (TRRFF)

FAQ's for Trifecta Gold Ltd (TRRFF)

  • As of August 2026, Trifecta Gold Ltd TRRFF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Trifecta Gold Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Trifecta Gold Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Trifecta Gold Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Trifecta Gold Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Trifecta Gold Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.